Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 4
1989 1
1992 1
1993 1
1994 4
1995 2
1997 2
1998 1
2000 1
2001 1
2002 2
2003 1
2005 1
2006 2
2007 6
2008 3
2009 2
2010 2
2011 4
2012 5
2013 5
2014 8
2015 5
2016 5
2017 7
2018 9
2019 10
2020 4
2021 4
2022 4
2023 4
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.
Fadini GP, Longato E, Morieri ML, Broglio F, Aimaretti G, Russo GT, Anichini R, Ghiani M, Avogaro A, Solini A; DARWIN‐Renal Study Investigators. Fadini GP, et al. Among authors: anichini r. Diabetes Obes Metab. 2025 Sep;27(9):5182-5191. doi: 10.1111/dom.16569. Epub 2025 Jul 2. Diabetes Obes Metab. 2025. PMID: 40600449 Free PMC article.
The Effect of Sex and Gender on Diabetic Complications.
Seghieri G, Policardo L, Anichini R, Franconi F, Campesi I, Cherchi S, Tonolo G. Seghieri G, et al. Among authors: anichini r. Curr Diabetes Rev. 2017;13(2):148-160. doi: 10.2174/1573399812666160517115756. Curr Diabetes Rev. 2017. PMID: 27183843 Review.
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
Fadini GP, Bonora BM, Ghiani M, Anichini R, Melchionda E, Fattor B, Fazion S, Meregalli G, Giaccari A, Avogaro A, Consoli A; GLIMPLES study investigators. Fadini GP, et al. Among authors: anichini r. Diabetes Obes Metab. 2024 Jun;26(6):2390-2400. doi: 10.1111/dom.15554. Epub 2024 Mar 13. Diabetes Obes Metab. 2024. PMID: 38477183
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.
Napoli R, Nicolucci A, Larosa M, Rossi MC, Candido R; RESTORE‐G (Retrospective analysis on the therapeutic approaches after GLP‐1 RA treatment in type 2 diabetes patients) Study Group. Napoli R, et al. Diabetes Obes Metab. 2024 Sep;26(9):3576-3586. doi: 10.1111/dom.15697. Epub 2024 Jun 10. Diabetes Obes Metab. 2024. PMID: 38853712
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.
Fadini GP, Longato E, Poletto S, Giaccari A, Ghiani M, Strazzabosco M, Trombetta M, Penno G, Avogaro A, Solini A, Consoli A; GLIMPLES study investigators and DARWIN‐Renal study investigators. Fadini GP, et al. Diabetes Obes Metab. 2025 Dec;27(12):7431-7440. doi: 10.1111/dom.70151. Epub 2025 Sep 24. Diabetes Obes Metab. 2025. PMID: 40990044 Free PMC article.
Increased Creatine Kinase May Predict A Worse COVID-19 Outcome.
Orsucci D, Trezzi M, Anichini R, Blanc P, Barontini L, Biagini C, Capitanini A, Comeglio M, Corsini P, Gemignani F, Giannecchini R, Giusti M, Lombardi M, Marrucci E, Natali A, Nenci G, Vannucci F, Volpi G. Orsucci D, et al. Among authors: anichini r. J Clin Med. 2021 Apr 16;10(8):1734. doi: 10.3390/jcm10081734. J Clin Med. 2021. PMID: 33923719 Free PMC article.
100 results